A phase I clinical trial has begun into a treatment that could prevent drug resistance in patients with acute myeloid leukaemia (AML) and other cancers. EP0042 is a dual inhibitor of cancer-driving proteins from the Aurora and...
1 month ago
Whole genome sequencing is as good as – if not better than – conventional genetic tests to help determine the best treatment for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), a new US study has reported. Res...
1 month ago